UAE approves AstraZeneca’s Baxfendy for hypertension
The regulatory approval is supported by data from two Phase III studies, BaxHTN and Bax24.
Drug Development
Isomorphic Labs receives $2.1bn for AI drug development
Partner Therapeutics secures FDA approval for Bizengri
ACROBiosystems upgrades HEK293 licence solution for R&D compliance
BMS’ Sotyktu secures EC approval for psoriatic arthritis
Construction begins on Novartis’ RLT centre in Texas, US
Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn
Daiichi Sankyo and Waiv partner for ADC biomarkers
